A Biotechnology ETF Proving Immune to Hawkish Fed Policy Changes

Biotechnology exchange traded funds are still scuffling on a year-to-date basis, but some members of that group have recently been showing signs of life, including the BioShares Biotechnology Products Fund (NasdaqGM: BBP). BBP is up more than 2% over the past month. For years, there were only five...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.